Therini Bio, Inc. — Form D/A

Therini Bio, Inc. of SACRAMENTO, CA, a company, filed a Form D amendment with the SEC on 2020-05-22. The offering totals $9.4M, of which $9.4M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (21)

NameRoleLocation
Aikaterini AkasoglouDirectorSOUTH SAN FRANCISCO, CA
Daniel BurgessDirectorNESS ZIONA, L3
Michael RossDirectorSouth San Francisco, CA
Tracy SaxtonDirectorKingston, RI
Daniel BurgessExecutive OfficerNESS ZIONA, L3
Leslie SchulzeExecutive OfficerSouth San Francisco, CA
Jeffrey Stavenhagen, Ph.D.Executive OfficerSouth San Francisco, CA
Olga D DanilchankaDirectorSacramento, CA
Laia D Crespo-MartinDirectorSacramento, CA
Leslie D SchulzeExecutive OfficerSacramento, CA
Daniel D BurgessDirectorSacramento, CA
Michael D RossDirectorSacramento, CA
Laurence BarkerDirectorBOSTON, MA
Tara NickersonDirectorSacramento, CA
Tara NickersonExecutive OfficerSacramento, CA
Houman D AshrafianDirectorSacramento, CA
Jeffrey D StavenhagenExecutive OfficerSacramento, CA
Michael QuigleyDirectorSacramento, CA
Michael QuigleyExecutive OfficerSacramento, CA
David D DolbyDirectorSacramento, CA
Edward SpackExecutive OfficerSAN FRANCISCO, CA

Other filings by this issuer (3)

FiledFormOfferingSold
2025-09-08D/A$80.8M$74.9M
2023-04-14D$54.6M$26.6M
2019-05-17D$6.5M$2.4M

More